Monday, October 26, 2026 · Daily editionET --:--:--

Finished

The (Cost)Effectiveness of a Social Robot for Persons With Problems in Daily Structure and Planning in Disability Care

NCT06592404 · Academy Het Dorp · Updated 2 July 2026

What is being tested
Robot Tessa
For
Brain Injury, Chronic; Intellectual Disability, Mild to Moderate; Autism Spectrum Disorder; Down Syndrome
Kind of study
Tests a treatment or device on volunteers. No drug phase (a device or procedure study).
Who can join
Ages 18 years and older. About 32 people. The full rules are on the registry page.
Where
Netherlands (4 sites)
When
Starts or started 29 Nov 2023, ends 21 Sept 2025. Registered 19 Sept 2024.
Results
None posted yet.

In the researchers' words

The goal of this multiple baseline single case study is to study the (cost)effectiveness of a social robot in reducing professional caregiver support and promoting independence for individuals in long-term disability care experiencing problems with daily structure and planning. The main research questions it aims to answer are: * What is the effect of the social robot on the frequency of moments professional caregivers support individuals experiencing problems with daily structure and planning with the execution of daily activities, compared to care as usual, after 6 weeks? * Does the effect of the social robot persist in the long term (after 6 months)? * What is the cost-effectiveness of the social robot? Participants will: * Use a social robot in their daily living environment * Answer survey questions about their quality of life and wellbeing during the study period * Share their experiences in interviews Their profesional caregivers will: * Register the frequency and duration of support they provide to the participant daily for 13 weeks and a 2-week follow-up * Give weekly updates and score participants' goal attainment while using the social robot * Fill in questionnaires on participants' productivity and health care consumption during the study period * Share their experiences in interviews
ClinicalTrials.gov, NCT06592404

Sites

  • SGLSittard, Limburg, Netherlands
  • Hartekamp GroepVelserbroek, North Holland, Netherlands
  • Ipse de BruggenZoetermeer, South Holland, Netherlands
  • AbronaHuis ter Heide, Utrecht, Netherlands